SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

Cash flow Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-02-12			5-day change	1st Jan Change
17.51 ^CNY	-1.19%		-1.07%	+2.58%

01-23	Yiling Pharma's Unit Gets Nod for Registration of Aniline Profen Injection	MT
01-23	Yiling Pharmaceutical Expects 2025 Profit Swing on Revenue Recovery, Cost Control	MT

b26aaba7aecf54d0719.0o14cs4mQnuhmDzT7lNNzFN_T89Btgq-jMcYSCm8DVs.otInE6hycQyR2RG_qTsHnDoPfb033U7V1Y8uHHbUQjWq7wlKgUokNsDbTw

Published financial data: SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.77B	10.11B	12.52B	10.31B	6.51B
Other Revenues, Total	8.42M	6.12M	13.04M	3.48M	6.99M
Total Revenues	8.78B	10.12B	12.53B	10.32B	6.51B
Cost of Goods Sold, Total	3.12B	3.7B	4.56B	4.43B	3.49B
Gross Profit	5.66B	6.42B	7.98B	5.88B	3.03B
Selling General & Admin Expenses, Total	3.44B	3.93B	3.87B	3.3B	2.93B
Provision for Bad Debts	5.04M	36.93M	16.62M	22.21M	10.54M
R&D Expenses	654M	792M	1.03B	853M	827M
Other Operating Expenses	136M	138M	203M	99.27M	91.72M
Other Operating Expenses, Total	4.23B	4.9B	5.12B	4.27B	3.86B
Operating Income	1.43B	1.52B	2.85B	1.61B	-837M
Interest Expense, Total	-3.85M	-33.97M	-33.8M	-38.9M	-29.01M
Interest And Investment Income	38.51M	20.45M	12.9M	42.04M	47.81M
Net Interest Expenses	34.66M	-13.53M	-20.9M	3.14M	18.8M
Currency Exchange Gains (Loss)	21.43K	-1.25M	4.16M	-215K	1.46M
Other Non Operating Income (Expenses)	-23.68M	-3.31M	-3.49M	-4.83M	-2.62M
EBT, Excl. Unusual Items	1.44B	1.5B	2.83B	1.61B	-819M
Impairment of Goodwill	-	-	-	-522K	-6.24M
Gain (Loss) On Sale Of Investments	5.23M	-21.9M	11.5M	39.35M	-
Gain (Loss) On Sale Of Assets	140K	-2.52M	-6.11M	-819K	-487K
Asset Writedown	-53.12M	-10.76M	-92.61M	-10.63M	-767K
Other Unusual Items	32.87M	88.23M	34.65M	45.88M	26.68M
EBT, Incl. Unusual Items	1.42B	1.55B	2.78B	1.68B	-800M
Income Tax Expense	208M	212M	424M	340M	-66.01M
Earnings From Continuing Operations	1.21B	1.34B	2.36B	1.34B	-734M
Net Income to Company	1.21B	1.34B	2.36B	1.34B	-734M
Minority Interest	3.81M	2.22M	4.98M	8.08M	9.67M
Net Income - (IS)	1.22B	1.34B	2.36B	1.35B	-725M
Net Income to Common Incl Extra Items	1.22B	1.34B	2.36B	1.35B	-725M
Net Income to Common Excl. Extra Items	1.22B	1.34B	2.36B	1.35B	-725M
Per Share Items
Net EPS - Basic	0.73	0.8	1.41	0.81	-0.43
Basic EPS - Continuing Operations	0.73	0.8	1.41	0.81	-0.43
Basic Weighted Average Shares Outstanding	1.67B	1.67B	1.67B	1.67B	1.67B
Net EPS - Diluted	0.73	0.8	1.41	0.81	-0.43
Diluted EPS - Continuing Operations	0.73	0.8	1.41	0.81	-0.43
Diluted Weighted Average Shares Outstanding	1.67B	1.67B	1.67B	1.67B	1.67B
Normalized Basic EPS	0.54	0.56	1.06	0.61	-0.3
Normalized Diluted EPS	0.54	0.56	1.06	0.61	-0.3
Dividend Per Share	0.71	0.3	0.5	0.3	-
Payout Ratio	20.03	90.79	11.97	64.54	-51.8
Supplemental Items
EBITDA	1.69B	1.87B	3.29B	2.15B	-236M
EBITA	1.45B	1.55B	2.89B	1.64B	-804M
EBIT	1.43B	1.52B	2.85B	1.61B	-837M
EBITDAR	1.7B	1.88B	3.31B	2.17B	-220M
Total Revenues (As Reported)	8.78B	10.12B	12.53B	10.32B	6.51B
Effective Tax Rate - (Ratio)	14.59	13.65	15.24	20.18	8.25
Total Current Taxes	275M	192M	583M	235M	132M
Total Deferred Taxes	-67.66M	20.14M	-159M	104M	-198M
Normalized Net Income	902M	940M	1.78B	1.01B	-502M
Interest on Long-Term Debt	411K	350K	1.8M	-	-
Non-Cash Pension Expense	2.3M	1.87M	7.63M	10.73M	49.59M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	170M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	3.04B	3.43B	3.26B	2.7B	2.33B
General and Administrative Expenses	400M	497M	612M	592M	600M
Research And Development Expense From Footnotes	654M	792M	1.08B	856M	827M
Net Rental Expense, Total	9.14M	9.84M	17.62M	15.93M	16.68M
Imputed Operating Lease Interest Expense	1.76M	3.57M	4.54M	4.33M	5.35M
Imputed Operating Lease Depreciation	7.38M	6.27M	13.08M	11.6M	11.32M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.34B	995M	1.9B	941M	853M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	217M	55.27M	518M	206M	-
Total Cash And Short Term Investments	1.55B	1.05B	2.42B	1.15B	853M
Accounts Receivable, Total	1.76B	2.36B	2.18B	2.6B	1.39B
Other Receivables	18.27M	12.11M	968K	5.59M	130M
Total Receivables	1.77B	2.37B	2.18B	2.6B	1.52B
Inventory	1.58B	1.67B	2.02B	2.46B	1.75B
Prepaid Expenses	93.12K	39.39M	898K	208K	26.09M
Other Current Assets, Total	550M	466M	630M	336M	189M
Total Current Assets	5.46B	5.6B	7.25B	6.54B	4.33B
Gross Property Plant And Equipment	5.89B	7.64B	8.45B	10.02B	10.51B
Accumulated Depreciation	-1.58B	-1.88B	-2.22B	-2.71B	-3.26B
Net Property Plant And Equipment	4.31B	5.76B	6.23B	7.31B	7.25B
Long-term Investments	1M	1M	3.5M	1.65B	3.47M
Goodwill	-	-	-	116M	110M
Other Intangibles, Total	480M	661M	724M	744M	803M
Deferred Tax Assets Long-Term	138M	117M	280M	184M	366M
Deferred Charges Long-Term	261M	239M	107M	189M	267M
Other Long-Term Assets, Total	840M	527M	1.74B	241M	183M
Total Assets	11.49B	12.9B	16.34B	16.98B	13.32B
Liabilities
Accounts Payable, Total	1.19B	1.62B	2.06B	2.85B	1.9B
Accrued Expenses, Total	335M	270M	645M	420M	351M
Short-term Borrowings	270M	702M	500M	600M	-
Current Portion of Long-Term Debt	-	-	150M	201M	-
Current Portion of Leases	-	13.43M	5.86M	5.5M	8.24M
Current Income Taxes Payable	59.4M	11.38M	242M	42.45M	23.46M
Unearned Revenue Current, Total	355M	302M	1.11B	288M	272M
Other Current Liabilities	30.87M	40.7M	140M	43.58M	55.26M
Total Current Liabilities	2.24B	2.96B	4.85B	4.45B	2.61B
Long-Term Debt	-	500M	200M	599M	-
Long-Term Leases	-	12.53M	14.97M	13.01M	18.21M
Unearned Revenue Non Current	328M	358M	335M	352M	378M
Deferred Tax Liability Non Current	2.02M	1.39M	5.56M	130M	114M
Total Liabilities	2.57B	3.83B	5.41B	5.54B	3.12B
Common Stock, Total	1.2B	1.67B	1.67B	1.67B	1.67B
Additional Paid In Capital	2.93B	2.34B	2.34B	2.34B	2.34B
Retained Earnings	4.91B	5.07B	6.93B	7.44B	6.22B
Treasury Stock	-122M	-	-	-	-
Comprehensive Income and Other	-9.08M	-9.71M	-7.22M	-6.61M	-7.12M
Total Common Equity	8.92B	9.07B	10.93B	11.45B	10.22B
Minority Interest	4.09M	3.04M	-1.95M	-11.73M	-21.4M
Total Equity	8.92B	9.07B	10.93B	11.44B	10.2B
Total Liabilities And Equity	11.49B	12.9B	16.34B	16.98B	13.32B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.67B	1.67B	1.67B	1.67B	1.67B
ECS Total Common Shares Outstanding	1.67B	1.67B	1.67B	1.67B	1.67B
Book Value / Share	5.35	5.43	6.54	6.85	6.12
Tangible Book Value	8.44B	8.41B	10.21B	10.59B	9.31B
Tangible Book Value Per Share	5.06	5.03	6.11	6.34	5.57
Total Debt	270M	1.23B	871M	1.42B	26.45M
Net Debt	-1.28B	178M	-1.55B	273M	-827M
Debt Equivalent Oper. Leases	73.13M	78.76M	141M	127M	133M
Minority Interest, Total (Incl. Fin. Div)	4.09M	3.04M	-1.95M	-11.73M	-21.4M
Equity Method Investments, Total	-	-	2.5M	2.48M	2.47M
Account Code - Inventory Valuation	5	5	5	5	6
Inventories - Raw Materials, Total	459M	312M	593M	354M	192M
Inventories - Work In Process, Total	290M	330M	580M	838M	704M
Inventories - Finished Goods, Total	838M	968M	735M	1.21B	982M
Inventories - Others	-	81.25M	131M	96.29M	124M
Buildings, Total	3B	3.62B	4.35B	5.41B	5.67B
Machinery, Total	1.5B	2B	2.48B	3.1B	3.58B
Full Time Employees	16.91K	15.16K	15.07K	13.96K	11.71K
Accumulated Allowance for Doubtful Accounts (Supple)	7.81M	44.4M	44.94M	65.1M	58.1M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.22B	1.34B	2.36B	1.35B	-725M
Depreciation & Amortization - CF	239M	328M	411M	516M	577M
Amortization of Goodwill and Intangible Assets - (CF)	25.24M	29.21M	35.66M	31.1M	33.28M
Depreciation & Amortization, Total	264M	358M	447M	547M	611M
Amortization of Deferred Charges, Total - (CF)	10.57M	10.16M	5.01M	4.11M	3.4M
(Gain) Loss From Sale Of Asset	-140K	2.52M	3.11M	819K	487K
(Gain) Loss on Sale of Investments - (CF)	-29.6M	-4.42M	-11.5M	-78.08M	-44.87M
Asset Writedown & Restructuring Costs	53.12M	10.76M	95.62M	11.15M	7M
Provision and Write-off of Bad Debts	5.04M	36.93M	16.62M	22.21M	10.54M
Other Operating Activities, Total	21.63M	51.24M	44.94M	56.82M	260M
Change In Accounts Receivable	-669M	-1.28B	-832M	-700M	638M
Change In Inventories	-365M	-105M	-348M	-460M	470M
Change In Accounts Payable	1.13B	55.15M	1.89B	-723M	-447M
Change In Deferred Taxes	-67.66M	20.14M	-159M	104M	-198M
Change in Other Net Operating Assets	17.67M	29.75M	-22.82M	17.35M	25.55M
Cash from Operations	1.59B	529M	3.49B	155M	611M
Capital Expenditure	-1.14B	-674M	-214M	-311M	-290M
Sale of Property, Plant, and Equipment	301K	1.2M	351K	966K	20.06K
Cash Acquisitions	-	-	-	-676M	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	78.94M	159M	-1.79B	49.1M	1.78B
Other Investing Activities, Total	25.34M	6.28M	7.66M	37.83M	117M
Cash from Investing	-1.04B	-507M	-1.99B	-899M	1.61B
Short Term Debt Issued, Total	490M	-	-	500M	282M
Long-Term Debt Issued, Total	-	2.4B	1.85B	1.2B	870M
Total Debt Issued	490M	2.4B	1.85B	1.7B	1.15B
Short Term Debt Repaid, Total	-270M	-	-	-393M	-782M
Long-Term Debt Repaid, Total	-	-1.48B	-2.2B	-655M	-2.28B
Total Debt Repaid	-270M	-1.48B	-2.2B	-1.05B	-3.06B
Issuance of Common Stock	-	-	-	-	30.5M
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-244M	-1.22B	-283M	-873M	-375M
Common & Preferred Stock Dividends Paid	-244M	-1.22B	-283M	-873M	-375M
Other Financing Activities, Total	837K	1.18M	-	-	-1.32M
Cash from Financing	-23.26M	-302M	-637M	-221M	-2.25B
Foreign Exchange Rate Adjustments	-1.95M	-481K	1.25M	326K	105K
Net Change in Cash	521M	-281M	857M	-964M	-30.03M
Supplemental Items
Cash Income Tax Paid (Refund)	1.16B	1.17B	1.32B	1.32B	711M
Levered Free Cash Flow	1.37B	252M	3.67B	104M	656M
Unlevered Free Cash Flow	1.37B	273M	3.69B	129M	675M
Change In Net Working Capital	-1.35B	370M	-1.67B	1.12B	-874M
Net Debt Issued / Repaid	220M	917M	-354M	652M	-1.91B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.67	7.78	12.2	6.05	-3.45
Return on Total Capital	10.37	9.74	16.14	8.18	-4.53
Return On Equity %	14.4	14.91	23.57	12.02	-6.79
Return on Common Equity	14.45	14.94	23.62	12.08	-6.69
Margin Analysis
Gross Profit Margin %	64.42	63.43	63.64	57.03	46.47
SG&A Margin	39.12	38.85	30.89	31.95	45.06
EBITDA Margin %	19.25	18.44	26.25	20.86	-3.63
EBITA Margin %	16.53	15.3	23.05	15.93	-12.34
EBIT Margin %	16.24	15.01	22.77	15.63	-12.85
Income From Continuing Operations Margin %	13.83	13.26	18.81	13.03	-11.27
Net Income Margin %	13.88	13.28	18.84	13.11	-11.12
Net Avail. For Common Margin %	13.88	13.28	18.84	13.11	-11.12
Normalized Net Income Margin	10.27	9.29	14.17	9.84	-7.71
Levered Free Cash Flow Margin	15.58	2.49	29.28	1.01	10.08
Unlevered Free Cash Flow Margin	15.61	2.7	29.45	1.25	10.36
Asset Turnover
Asset Turnover	0.85	0.83	0.86	0.62	0.43
Fixed Assets Turnover	2.38	2.01	2.09	1.52	0.89
Receivables Turnover (Average Receivables)	4.24	4.91	5.52	4.32	3.26
Inventory Turnover (Average Inventory)	2.23	2.27	2.47	1.98	1.66
Short Term Liquidity
Current Ratio	2.44	1.89	1.5	1.47	1.66
Quick Ratio	1.49	1.16	0.95	0.84	0.91
Operating Cash Flow to Current Liabilities	0.71	0.18	0.72	0.03	0.23
Days Sales Outstanding (Average Receivables)	86.33	74.32	66.16	84.47	112.14
Days Outstanding Inventory (Average Inventory)	164.1	160.47	147.98	184.41	220.73
Average Days Payable Outstanding	89.06	135.21	136.98	183.86	312.91
Cash Conversion Cycle (Average Days)	161.38	99.57	77.16	85.02	19.96
Long Term Solvency
Total Debt/Equity	3.03	13.55	7.97	12.41	0.26
Total Debt / Total Capital	2.94	11.93	7.38	11.04	0.26
LT Debt/Equity	-	5.65	1.97	5.35	0.18
Long-Term Debt / Total Capital	-	4.98	1.82	4.76	0.18
Total Liabilities / Total Assets	22.35	29.7	33.09	32.64	23.4
EBIT / Interest Expense	370.77	44.7	84.43	41.46	-28.86
EBITDA / Interest Expense	439.49	55.23	97.66	55.53	-7.8
(EBITDA - Capex) / Interest Expense	141.91	35.4	91.33	47.53	-17.82
Total Debt / EBITDA	0.16	0.65	0.26	0.66	-0.12
Net Debt / EBITDA	-0.76	0.1	-0.47	0.13	3.65
Total Debt / (EBITDA - Capex)	0.49	1.02	0.28	0.77	-0.05
Net Debt / (EBITDA - Capex)	-2.35	0.15	-0.5	0.15	1.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	50.76	15.19	23.88	-17.67	-36.88
Gross Profit, 1 Yr. Growth %	52.13	13.42	24.3	-26.23	-48.57
EBITDA, 1 Yr. Growth %	85.68	10.12	75.79	-34.67	-110.98
EBITA, 1 Yr. Growth %	117.12	6.36	86	-43.18	-148.8
EBIT, 1 Yr. Growth %	119.16	6.48	87.88	-43.48	-151.9
Earnings From Cont. Operations, 1 Yr. Growth %	101.47	10.43	75.67	-42.98	-154.61
Net Income, 1 Yr. Growth %	100.95	10.27	75.75	-42.76	-153.57
Normalized Net Income, 1 Yr. Growth %	111.43	4.21	88.88	-41.91	-149.51
Diluted EPS Before Extra, 1 Yr. Growth %	100	10.27	75.75	-42.76	-153.58
Accounts Receivable, 1 Yr. Growth %	-26.3	34.44	-7.77	19.23	-46.46
Inventory, 1 Yr. Growth %	29.34	5.85	20.87	21.61	-28.97
Net Property, Plant and Equip., 1 Yr. Growth %	40.93	33.5	8.19	17.37	-0.8
Total Assets, 1 Yr. Growth %	26.72	12.29	26.59	3.91	-21.56
Tangible Book Value, 1 Yr. Growth %	12.83	-0.36	21.4	3.75	-12.08
Common Equity, 1 Yr. Growth %	12.27	1.68	20.54	4.73	-10.71
Cash From Operations, 1 Yr. Growth %	2.2K	-66.67	559.69	-95.54	293.04
Capital Expenditures, 1 Yr. Growth %	151.92	-41.16	-68.23	45.26	-6.58
Levered Free Cash Flow, 1 Yr. Growth %	-425.7	-81.53	1.36K	-97.16	540.18
Unlevered Free Cash Flow, 1 Yr. Growth %	-426.31	-80.07	1.25K	-96.51	431.77
Dividend Per Share, 1 Yr. Growth %	399.86	-58	66.67	-40	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	35.06	31.78	19.46	0.99	-27.91
Gross Profit, 2 Yr. CAGR %	33.42	31.36	18.74	-4.24	-38.4
EBITDA, 2 Yr. CAGR %	34.75	43.16	39.33	7.24	-73.21
EBITA, 2 Yr. CAGR %	44.38	52.16	40.89	2.88	-47.3
EBIT, 2 Yr. CAGR %	45.04	52.76	41.44	3.05	-45.84
Earnings From Cont. Operations, 2 Yr. CAGR %	43.14	49.16	39.28	0.1	-44.2
Net Income, 2 Yr. CAGR %	42.61	48.85	39.21	0.32	-44.62
Normalized Net Income, 2 Yr. CAGR %	42.65	48.44	40.3	3.9	-46.37
Diluted EPS Before Extra, 2 Yr. CAGR %	42.84	48.6	39.21	0.32	-44.62
Accounts Receivable, 2 Yr. CAGR %	-4.78	-0.46	11.35	4.87	-20.1
Inventory, 2 Yr. CAGR %	15.94	17.01	13.11	21.24	-7.06
Net Property, Plant and Equip., 2 Yr. CAGR %	22.75	37.17	20.18	12.68	7.9
Total Assets, 2 Yr. CAGR %	15.89	19.29	19.23	14.71	-9.72
Tangible Book Value, 2 Yr. CAGR %	8.2	6.03	9.98	12.23	-4.49
Common Equity, 2 Yr. CAGR %	8.61	6.84	10.71	12.36	-3.3
Cash From Operations, 2 Yr. CAGR %	368.17	176.96	48.28	-45.77	-58.14
Capital Expenditures, 2 Yr. CAGR %	147.27	21.75	-56.77	-32.07	16.49
Levered Free Cash Flow, 2 Yr. CAGR %	120.12	-22.56	64.04	-35.65	-57.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	120.32	-19.36	64.1	-31.38	-57.25
Dividend Per Share, 2 Yr. CAGR %	216.29	44.89	-16.33	0	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	29.1	28.08	29.1	5.52	-13.65
Gross Profit, 3 Yr. CAGR %	26.77	26.39	28.96	1.32	-22.16
EBITDA, 3 Yr. CAGR %	26.11	26.07	53.45	8.29	-49.82
EBITA, 3 Yr. CAGR %	32.98	30.51	62.88	4.14	-19.72
EBIT, 3 Yr. CAGR %	33.59	30.84	63.67	4.18	-18.01
Earnings From Cont. Operations, 3 Yr. CAGR %	31.3	31.28	57.52	3.43	-18.21
Net Income, 3 Yr. CAGR %	31.11	30.89	57.33	3.53	-18.61
Normalized Net Income, 3 Yr. CAGR %	32.38	28.47	60.85	4	-18.85
Diluted EPS Before Extra, 3 Yr. CAGR %	31.37	31.09	57.14	3.53	-18.61
Accounts Receivable, 3 Yr. CAGR %	13.02	6.83	-2.96	13.92	-16.19
Inventory, 3 Yr. CAGR %	13.69	12.47	18.28	15.87	1.45
Net Property, Plant and Equip., 3 Yr. CAGR %	12.78	26.23	26.73	19.24	8
Total Assets, 3 Yr. CAGR %	13.37	14.68	21.67	13.89	1.06
Tangible Book Value, 3 Yr. CAGR %	7.69	5.27	10.92	7.86	3.46
Common Equity, 3 Yr. CAGR %	7.85	6.25	11.23	8.68	4.07
Cash From Operations, 3 Yr. CAGR %	140.06	94.04	269.87	-53.89	4.94
Capital Expenditures, 3 Yr. CAGR %	85.16	53.23	-22.2	-35.25	-24.46
Levered Free Cash Flow, 3 Yr. CAGR %	136.23	-3.73	105.96	-57.55	37.61
Unlevered Free Cash Flow, 3 Yr. CAGR %	141.18	-1.1	106.36	-54.56	35.17
Dividend Per Share, 3 Yr. CAGR %	115.47	61.36	51.81	-25.11	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.49	21.32	25.16	16.47	2.26
Gross Profit, 5 Yr. CAGR %	22.87	20.11	23.49	13.11	-4.04
EBITDA, 5 Yr. CAGR %	21.51	17.38	31.3	18.24	-23.63
EBITA, 5 Yr. CAGR %	23.38	19.39	36.16	18.74	3.75
EBIT, 5 Yr. CAGR %	23.64	19.66	36.68	18.92	5.16
Earnings From Cont. Operations, 5 Yr. CAGR %	23.27	20.63	34.43	17.79	4.01
Net Income, 5 Yr. CAGR %	23.14	20.33	34.29	17.68	3.62
Normalized Net Income, 5 Yr. CAGR %	23.38	19.19	35.49	18.02	3.32
Diluted EPS Before Extra, 5 Yr. CAGR %	21.84	19.1	34.48	17.78	3.55
Accounts Receivable, 5 Yr. CAGR %	27.37	23.79	12.35	6.04	-10.22
Inventory, 5 Yr. CAGR %	8.77	12.52	13.45	15.9	7.41
Net Property, Plant and Equip., 5 Yr. CAGR %	9.55	13.78	15.68	20.63	18.84
Total Assets, 5 Yr. CAGR %	15.03	15.58	15.68	14.69	7.99
Tangible Book Value, 5 Yr. CAGR %	13.62	11.1	8.6	8	4.48
Common Equity, 5 Yr. CAGR %	13.12	11.25	8.98	8.65	5.17
Cash From Operations, 5 Yr. CAGR %	64.45	-3.79	97.98	16.52	54.72
Capital Expenditures, 5 Yr. CAGR %	19.06	12.5	3.48	10.67	-8.57
Levered Free Cash Flow, 5 Yr. CAGR %	108.21	11.86	104.03	-18.06	9.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	104.82	12.86	106.75	-14.55	9.94
Dividend Per Share, 5 Yr. CAGR %	58.5	33.26	47.59	33.26	-